Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. - Wikidata - wikimedia - TriplyDB

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

http://www.wikidata.org/entity/Q37416054

about

Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Autophagy-Dependent Secretion: Contribution to Tumor Progression Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients.Frailty and inflammatory markers in older adults with cancer The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma.Ipilimumab for patients with advanced mucosal melanoma.Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.Validation of prognostic scores for survival in cancer patients beyond first-line therapy.Oncogene withdrawal engages the immune system to induce sustained cancer regression.Prognostic value of preoperative absolute lymphocyte count in recurrent hepatocellular carcinoma following thermal ablation: a retrospective analysis An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival.The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.Novel immunological and nutritional-based prognostic index for gastric cancer.Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision.Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)Distinguishing Benign Mediastinal Masses from Malignancy in a Histoplasmosis-Endemic Region.Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.Analysis of prognostic factors in lymphoma patients with bone marrow involvement: a single center cohort study.Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer.Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer.

P2860

Q26781215-29E2042C-510D-43C6-824C-E20661A4B1A9 Q28078649-A080C741-ADE0-4212-9F94-44AF91893DAC Q28084138-3585DE24-C088-4FB5-A5E8-6A04969FBE6F Q30449589-2816CF97-C520-44F6-A7A0-36068B441243 Q33397854-7DED3E5B-F0D7-4CC4-9806-1B7E56E11ED0 Q33417528-10DF0312-90A2-4A4B-AE9A-005A14E6294B Q33563551-8E0878E8-C305-4419-9805-8F6368308278 Q33613591-82ED7750-8842-4CF2-A11B-3F3E17E97D59 Q33743191-A3A60FE6-A43D-43B6-8509-55BE8D889596 Q33777469-57AD646D-4921-43F9-A0F0-7973C411D8A6 Q33844570-4952443F-5223-4A5F-BAC9-F089B5143148 Q33846615-76E8488E-0187-4556-8725-C65820D58078 Q33987633-1CEC23AF-8CB7-447D-B604-99AB5CBB58F3 Q34352741-EA906814-480A-4B92-BE9C-50106B496613 Q34361976-65F4892B-A3B1-40CB-890A-158CFEEC9ACB Q34388117-BC35247B-34B8-45A6-916F-E7075A14EFFA Q34633368-DA23146F-EF05-4751-BD09-E292E0DA6996 Q34646737-E854C880-757A-48B6-8384-9D61F3CCF106 Q34659530-1A129AAD-C88C-4D03-A8C1-36A13D154E51 Q35151707-95981A04-5443-4C87-B05C-59D7A585602A Q35207251-31F8E428-A022-440E-B2E7-13D3ADE01310 Q35530179-D9413A59-9CB9-4FE7-B354-311F0E681710 Q35544697-F323F78D-C3A9-43F7-85CB-FEFD1E9504B7 Q35625425-0B3D1B6B-85EC-4F4A-BC06-30B0DDB937AF Q35665693-48C34492-7C75-4DDB-A302-D7EFD9A38600 Q35692835-1BCF749F-1AA5-4E64-BAE7-6EE41BEF5F14 Q35739526-1CDD7C0D-17F7-43A9-BB4B-9750FD71C0F5 Q35772513-62078797-0AE0-4C07-8C8E-B7FFA635A031 Q35791247-62E37173-6F80-436D-84B5-ECF59977D079 Q35797850-4297C19D-C181-4C4A-B425-F3132948240B Q35847903-D3E49C0A-D1EF-4E81-B391-BCA4D2231CCC Q35884149-D30D0161-228A-4106-B5EB-44670DB617D9 Q35889913-712F4B12-C039-4160-8A69-10FA5559D21C Q35893943-8AD853F7-6240-4DA1-B6D8-27C80F7E2A93 Q35897794-29ABC66A-BF73-43C3-BB47-241160CAA559 Q35948012-DB00E18A-16CF-4649-BF0A-89082155E135 Q35959252-DEEFD8C5-0B49-4160-89ED-4843F582BE99 Q36057423-505FD638-ADDC-4E73-A85F-42114CC6E61F Q36057482-BC8D4FFE-1940-48B1-BBD5-851731E6D6C7 Q36130532-373D1F35-158D-4D94-BC15-5BF69ACD1038

P2860

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

http://www.wikidata.org/entity/Q37416054

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lymphopenia as a prognostic fa ...... omas, sarcomas, and lymphomas.

@en

Lymphopenia as a prognostic fa ...... omas, sarcomas, and lymphomas.

@nl

type

label

Lymphopenia as a prognostic fa ...... omas, sarcomas, and lymphomas.

@en

Lymphopenia as a prognostic fa ...... omas, sarcomas, and lymphomas.

@nl

prefLabel

Lymphopenia as a prognostic fa ...... omas, sarcomas, and lymphomas.

@en

Lymphopenia as a prognostic fa ...... omas, sarcomas, and lymphomas.

@nl

P1433

Q37416054-95009D87-1E1E-4648-97AE-17D877D001DF

P1476

Q37416054-E56EC029-339E-447F-A016-6C924F965E55

P2093

Q37416054-0F9F92C9-3D6A-4182-88E1-DC6B489F37C9

Q37416054-138A1663-1DE1-459E-89DB-D0278DC3E16A

Q37416054-23FCD0E4-09AC-4F8E-AB0F-802DD4C7A7A9

Q37416054-3753DE6F-A5FD-491A-9105-D5D633349688

Q37416054-7C4490C6-5B27-4752-9827-0DA138204AC1

Q37416054-808B0C20-FA13-48A2-9717-B2DB42A051AD

Q37416054-8F0B4F1B-3A03-482C-BEBD-ED4257E83537

Q37416054-A118723B-CD4B-41E4-9E17-6B09B24F6639

Q37416054-B503B75E-D6DF-4D96-9BE9-51ECDD366D71

Q37416054-B7B64915-1613-4B69-B75F-D7D38F609307

P2860

Q37416054-0471C0F1-845B-4DBD-8B2C-8C1C4E65C35A

Q37416054-0EF31A74-0039-4288-A246-A7FA5ABA2622

Q37416054-0F868C12-1BF7-463D-812E-975B4B8711E1

Q37416054-2711CEB5-6357-4945-8F3C-F99CB8F8B2DA

Q37416054-2A6F37FD-C3E3-492D-87DF-3A8E7DDAE468

Q37416054-2CA20715-B1F7-465C-99D8-36FB296F5E9E

Q37416054-37B153E7-2FFF-4BD4-8194-73B50EBF0EB3

Q37416054-3FE7A700-D8B5-498D-95AB-B8C6EA03BB76

Q37416054-49EB448A-45C5-4B05-9956-B536560E2F76

Q37416054-4C6C0162-6D68-422B-A1B2-70C493CE9FE0

P304

Q37416054-D683C62F-B28D-4896-BCB3-B64C443A7333

P31

Q37416054-D9A9AB91-D8AA-4A08-802D-7F5AC734EBD4

P356

Q37416054-4BFCAB06-EBA8-424A-8917-6064D4621A3A

P407

Q37416054-910CB347-217E-43AD-95B5-9658B80DF35C

P433

Q37416054-C0C03AE1-7BA0-40CD-B893-B13D5E8C829B

P478

Q37416054-7AA190AC-8BE9-42EC-A989-775EB9BFBDAB

P50

Q37416054-210FD3FC-EA57-4C3D-BB1F-9F2AC8362389

Q37416054-BD7C7BDA-4D19-4FBA-A48C-B7EEAE43956C

Q37416054-C2E303D9-F02B-4229-93F9-B4DCD51C8164

P577

Q37416054-8A94D023-A6CC-48F1-87E7-CFA1EF238926

P698

Q37416054-F2C09C83-212C-4A54-961E-DED0F7795D94

P932

Q37416054-47E5DED7-DDF0-452B-9565-2E08FF6D2B88

P356

0008-5472.CAN-08-3845

P1433

Cancer Research

P1476

Lymphopenia as a prognostic fa ...... omas, sarcomas, and lymphomas.

@en

P2093

Armelle Dufresne

http://www.w3.org/2001/XMLSchema#string

Catherine Sebban

http://www.w3.org/2001/XMLSchema#string

Claire Cropet

http://www.w3.org/2001/XMLSchema#string

David Perol

http://www.w3.org/2001/XMLSchema#string

European Organization for Rese ...... Tissue and Bone Sarcoma Group

http://www.w3.org/2001/XMLSchema#string

Ian Judson

http://www.w3.org/2001/XMLSchema#string

Inthidar Labidi

http://www.w3.org/2001/XMLSchema#string

Jaap Verweij

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Guastalla

http://www.w3.org/2001/XMLSchema#string

Martine Van Glabbeke

http://www.w3.org/2001/XMLSchema#string

P2860

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.

A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy.

Selecting and maintaining a diverse T-cell repertoire.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia?

Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses.

Transforming growth factor-beta in T-cell biology.

P304

5383-5391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-3845

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Ray-Coquard

P577

2009-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19549917

http://www.w3.org/2001/XMLSchema#string

P932

2775079

http://www.w3.org/2001/XMLSchema#string